191 related articles for article (PubMed ID: 20307292)
1. Phenotypic analysis of images of zebrafish treated with Alzheimer's gamma-secretase inhibitors.
Arslanova D; Yang T; Xu X; Wong ST; Augelli-Szafran CE; Xia W
BMC Biotechnol; 2010 Mar; 10():24. PubMed ID: 20307292
[TBL] [Abstract][Full Text] [Related]
2. Quantification of gamma-secretase modulation differentiates inhibitor compound selectivity between two substrates Notch and amyloid precursor protein.
Yang T; Arslanova D; Gu Y; Augelli-Szafran C; Xia W
Mol Brain; 2008 Nov; 1():15. PubMed ID: 18983676
[TBL] [Abstract][Full Text] [Related]
3. In vivo manifestation of Notch related phenotypes in zebrafish treated with Alzheimer's amyloid reducing gamma-secretase inhibitors.
Yang T; Arslanova D; Xu X; Li YM; Xia W
J Neurochem; 2010 Jun; 113(5):1200-9. PubMed ID: 20345767
[TBL] [Abstract][Full Text] [Related]
4. Gleevec increases levels of the amyloid precursor protein intracellular domain and of the amyloid-beta degrading enzyme neprilysin.
Eisele YS; Baumann M; Klebl B; Nordhammer C; Jucker M; Kilger E
Mol Biol Cell; 2007 Sep; 18(9):3591-600. PubMed ID: 17626163
[TBL] [Abstract][Full Text] [Related]
5. A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish.
Geling A; Steiner H; Willem M; Bally-Cuif L; Haass C
EMBO Rep; 2002 Jul; 3(7):688-94. PubMed ID: 12101103
[TBL] [Abstract][Full Text] [Related]
6. C-terminal fragment of presenilin is the molecular target of a dipeptidic gamma-secretase-specific inhibitor DAPT (N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester).
Morohashi Y; Kan T; Tominari Y; Fuwa H; Okamura Y; Watanabe N; Sato C; Natsugari H; Fukuyama T; Iwatsubo T; Tomita T
J Biol Chem; 2006 May; 281(21):14670-6. PubMed ID: 16569643
[TBL] [Abstract][Full Text] [Related]
7. Gleevec inhibits beta-amyloid production but not Notch cleavage.
Netzer WJ; Dou F; Cai D; Veach D; Jean S; Li Y; Bornmann WG; Clarkson B; Xu H; Greengard P
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12444-9. PubMed ID: 14523244
[TBL] [Abstract][Full Text] [Related]
8. JLK isocoumarin inhibitors: selective gamma-secretase inhibitors that do not interfere with notch pathway in vitro or in vivo.
Petit A; Pasini A; Alves Da Costa C; Ayral E; Hernandez JF; Dumanchin-Njock C; Phiel CJ; Marambaud P; Wilk S; Farzan M; Fulcrand P; Martinez J; Andrau D; Checler F
J Neurosci Res; 2003 Nov; 74(3):370-7. PubMed ID: 14598313
[TBL] [Abstract][Full Text] [Related]
9. Evidence of a novel mechanism for partial γ-secretase inhibition induced paradoxical increase in secreted amyloid β protein.
Barnwell E; Padmaraju V; Baranello R; Pacheco-Quinto J; Crosson C; Ablonczy Z; Eckman E; Eckman CB; Ramakrishnan V; Greig NH; Pappolla MA; Sambamurti K
PLoS One; 2014; 9(3):e91531. PubMed ID: 24658363
[TBL] [Abstract][Full Text] [Related]
10. The role of γ-secretase activating protein (GSAP) and imatinib in the regulation of γ-secretase activity and amyloid-β generation.
Hussain I; Fabrègue J; Anderes L; Ousson S; Borlat F; Eligert V; Berger S; Dimitrov M; Alattia JR; Fraering PC; Beher D
J Biol Chem; 2013 Jan; 288(4):2521-31. PubMed ID: 23209290
[TBL] [Abstract][Full Text] [Related]
11. Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease.
He G; Luo W; Li P; Remmers C; Netzer WJ; Hendrick J; Bettayeb K; Flajolet M; Gorelick F; Wennogle LP; Greengard P
Nature; 2010 Sep; 467(7311):95-8. PubMed ID: 20811458
[TBL] [Abstract][Full Text] [Related]
12. Gleevec shifts APP processing from a β-cleavage to a nonamyloidogenic cleavage.
Netzer WJ; Bettayeb K; Sinha SC; Flajolet M; Greengard P; Bustos V
Proc Natl Acad Sci U S A; 2017 Feb; 114(6):1389-1394. PubMed ID: 28115709
[TBL] [Abstract][Full Text] [Related]
13. gamma-Secretase substrate selectivity can be modulated directly via interaction with a nucleotide-binding site.
Fraering PC; Ye W; LaVoie MJ; Ostaszewski BL; Selkoe DJ; Wolfe MS
J Biol Chem; 2005 Dec; 280(51):41987-96. PubMed ID: 16236717
[TBL] [Abstract][Full Text] [Related]
14. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
[TBL] [Abstract][Full Text] [Related]
15. Proton myo-inositol cotransporter is a novel γ-secretase associated protein that regulates Aβ production without affecting Notch cleavage.
Teranishi Y; Inoue M; Yamamoto NG; Kihara T; Wiehager B; Ishikawa T; Winblad B; Schedin-Weiss S; Frykman S; Tjernberg LO
FEBS J; 2015 Sep; 282(17):3438-51. PubMed ID: 26094765
[TBL] [Abstract][Full Text] [Related]
16. Γ-secretase modulators do not induce Aβ-rebound and accumulation of β-C-terminal fragment.
Li T; Huang Y; Jin S; Ye L; Rong N; Yang X; Ding Y; Cheng Z; Zhang J; Wan Z; Harrison DC; Hussain I; Hall A; Lee DH; Lau LF; Matsuoka Y
J Neurochem; 2012 Apr; 121(2):277-86. PubMed ID: 22035227
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of γ-Secretase Leads to an Increase in Presenilin-1.
Sogorb-Esteve A; García-Ayllón MS; Llansola M; Felipo V; Blennow K; Sáez-Valero J
Mol Neurobiol; 2018 Jun; 55(6):5047-5058. PubMed ID: 28815510
[TBL] [Abstract][Full Text] [Related]
18. APPepsilon, the epsilon-secretase-derived N-terminal product of the beta-amyloid precursor protein, behaves as a type I protein and undergoes alpha-, beta-, and gamma-secretase cleavages.
Lefranc-Jullien S; Sunyach C; Checler F
J Neurochem; 2006 May; 97(3):807-17. PubMed ID: 16524370
[TBL] [Abstract][Full Text] [Related]
19. The γ-secretase blocker DAPT impairs recovery from lipopolysaccharide-induced inflammation in rat brain.
Nasoohi S; Hemmati AA; Moradi F; Ahmadiani A
Neuroscience; 2012 May; 210():99-109. PubMed ID: 22445932
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of selective inhibition of γ-secretase by avagacestat.
Albright CF; Dockens RC; Meredith JE; Olson RE; Slemmon R; Lentz KA; Wang JS; Denton RR; Pilcher G; Rhyne PW; Raybon JJ; Barten DM; Burton C; Toyn JH; Sankaranarayanan S; Polson C; Guss V; White R; Simutis F; Sanderson T; Gillman KW; Starrett JE; Bronson J; Sverdlov O; Huang SP; Castaneda L; Feldman H; Coric V; Zaczek R; Macor JE; Houston J; Berman RM; Tong G
J Pharmacol Exp Ther; 2013 Mar; 344(3):686-95. PubMed ID: 23275065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
